OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Tiacci on Vemurafenib and Rituximab Combo in Hairy Cell Leukemia

November 28th 2019

Enrico Tiacci, MD, discusses updated data of a phase II trial investigating the combination of vemurafenib and rituximab for patients with relapsed/refractory hairy cell leukemia.

Dr. Levy on First-Line Treatment for Nondriver NSCLC

November 28th 2019

Benjamin P. Levy, MD, discusses first-line treatment for patients with nondriver non–small cell lung cancer.

Dr. Patel on CheckMate-227 Results in Advanced NSCLC

November 27th 2019

Jyoti D. Patel, MD, discusses the results of the CheckMate-227 trial, which looked at an immunotherapy combination versus chemotherapy in patients with advanced non–small cell lung cancer.

Dr. Morris on Safety Profiles of AR Inhibitors in Prostate Cancer

November 27th 2019

David Morris, MD, FACS, discusses the safety profiles and common adverse events related to the androgen receptor inhibitors apalutamide, enzalutamide, and darolutamide for prostate cancer.

Dr. McBride on the Emergence of Biosimilars in Oncology

November 27th 2019

Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, discusses factors that need to be taken into consideration as biosimilars emerge in oncology.

Dr. Giralt on Current Standard of Care for Newly Diagnosed Multiple Myeloma

November 27th 2019

Sergio A. Giralt, MD, discusses the current frontline standard of care for patients with multiple myeloma.

Dr. Braunstein on the Bone Marrow Microenvironment in Multiple Myeloma

November 27th 2019

Marc J. Braunstein, MD, PhD, discusses challenges pertaining to the bone marrow microenvironment in multiple myeloma.

Dr. Perez-Soler on the Utility of Liquid Biopsy in Lung Cancer

November 27th 2019

Roman Perez-Soler, MD, discusses the utility of liquid biopsy in lung cancer.

Dr. Ferris on Combining STING Agonists With Checkpoint Inhibitors in Head and Neck Cancer

November 27th 2019

Robert L. Ferris, MD, PhD, discusses combining STING agonists with checkpoint inhibitors in head and neck cancer.

Dr. Drilon on Comprehensive Sequencing in Lung Cancer

November 26th 2019

Alexander Drilon, MD, discusses performing comprehensive sequencing in lung cancer.

Dr. Chari on Quadruplet Regimens in Transplant-Eligible Multiple Myeloma

November 26th 2019

Ajai Chari, MD, discusses the implementing quadruplet-regimens in transplant-eligible multiple myeloma.

Dr. Stadtmauer on BCMA-Targeting in Multiple Myeloma

November 26th 2019

Edward A. Stadtmauer, MD, discusses what makes BCMA a unique target in multiple myeloma.

Dr. Mailankody on MRD-Negative Status in Multiple Myeloma

November 23rd 2019

Sham Mailankody, MBBS, discusses minimal residual disease negativity in multiple myeloma.

Dr. Mato on Ibrutinib Versus Acalabrutinib in CLL

November 23rd 2019

Anthony R. Mato, MD, MSCE, discusses differences between the use of ibrutinib (Imbruvica) and acalabrutinib (Calquence) in chronic lymphocytic leukemia (CLL).

Dr. Rajdev on the Use of Somatostatin Analogs in Neuroendocrine Tumors

November 23rd 2019

Lakshmi N. Rajdev, MD, discusses the use of somatostatin analogs in patients with neuroendocrine tumors.

Dr. Weber on Adjuvant Pembrolizumab in Melanoma

November 23rd 2019

Jeffrey S. Weber, MD, PhD, discusses the phase III EORTC1325/KEYNOTE-054 trial, which looked at adjuvant pembrolizumab in patients with stage III melanoma.

Dr. Salani Discusses Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in Ovarian Cancer

November 22nd 2019

Ritu Salani, MD, discusses considerations for neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.

Dr. Gross on the Prognosis of Cutaneous Squamous Cell Carcinoma of the Head and Neck

November 22nd 2019

Neil D. Gross, MD, FACS, discusses the prognosis of patients who are diagnosed with cutaneous squamous cell carcinoma of the head and neck.

Dr. Fidler on the FLAURA Trial in EGFR-Mutant NSCLC

November 22nd 2019

Mary J. Fidler, MD, discusses overall survival data of the phase III FLAURA trial looking at frontline osimertinib in EGFR-mutant non–small cell lung cancer.

Dr. Patel on Immunotherapy Combinations in Lung Cancer

November 22nd 2019

Jyoti D. Patel, MD, discusses immunotherapy combinations for patients with advanced nonsquamous non–small cell lung cancer.